Clinical Trial: Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Study Status: Completed
Recruit Status: RECRUITING
Condition: Carcinoma, Non-Small-Cell Lung
Study Type: INTERVENTIONAL
Official Title: Subcutaneous Methotrexate, Oral Dexamethasone or Oral Montelukast for the Prevention of Infusion Related Reaction Associated With Amivantamab, an EGFR-MET Bispecific Antibody, Among Post-osimertinib T
Brief Summary:
The purpose of the study is to separately assess the potential of dexamethasone, montelukast and methotrexate administration, prior to amivantamab infusion given through a needle in the vein, to decrease the incidence and/or severity of first-dose infusion related reactions.
Read more